Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;45(10):3387-9.
doi: 10.1128/JCM.00580-07. Epub 2007 Aug 15.

Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin

Fernanda C Q Mello  1 , Mayra S Arias, Senia Rosales, Anna Grazia Marsico, Ada Pavón, Carlos Alvarado-Gálvez, Carlos Leonardo Carvalho Pessôa, Melly Pérez, Monica K Andrade, Afranio L Kritski, Leila S Fonseca, Richard E Chaisson, Michael E Kimerling, Susan E Dorman
Affiliations

Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin

Fernanda C Q Mello et al. J Clin Microbiol. 2007 Oct.

Abstract

This prospective study evaluated the performance of the microscopic observation drug susceptibility (MODS) assay for the direct detection of Mycobacterium tuberculosis drug resistance. MODS assay sensitivity, specificity, and positive and negative predictive values were 96.7% (95% confidence interval [95% CI], 92.1 to 98.8%), 78.4% (95% CI, 73.5 to 80.6%), 82.4% (95% CI, 78.4 to 84.2%), and 95.8% (95% CI, 89.9 to 98.5%), respectively, for isoniazid resistance and 96.0% (95% CI, 90.3 to 98.6%), 82.9% (95% CI, 78.8 to 84.7%), 80.0% (95% CI, 75.2 to 82.1%), and 96.7% (95% CI, 91.9 to 98.8%), respectively, for rifampin resistance. For both rifampin and isoniazid testing, the likelihood ratio for a negative test was < or =0.05, indicating that the MODS assay may be useful for ruling out drug resistance.

PubMed Disclaimer

References

    1. Arias, M., F. C. Q. Mello, A. Pavon, A. G Marsico, C. Alvarado-Galvez, S. Rosales, C. Pessoa, M. Perez, M. Andrade, A. L. Kritski, L. S. Fonseca, R. E Chaisson, M. E. Kimerling, and S. E. Dorman. 2007. Clinical evaluation of the microscopic-observation drug-susceptibility (MODS) assay for detection of tuberculosis. Clin. Infect. Dis. 44:674-680. - PubMed
    1. Canetti, G., W. Fox, A. Kohmenko, H. Mahler, N. K. Menon, and D. A. Mitchison. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43. - PMC - PubMed
    1. Caviedes, L., T. S. Lee, R. Gilman, P. Sheen, E. Spellman, E. H. Lee, D. E. Berg, S. Montegegro-James, and the Tuberculosis Working Group in Peru. 2000. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J. Clin. Microbiol. 38:1203-1208. - PMC - PubMed
    1. Ghandi, N. R, A. Moll, R. Pawinski, A. W. Sturm, U. Lalloo, K. Zeller, et al. 2006. High prevalence and mortality from extensively-drug resistant (XDR) TB in TB/HIV coinfected patients in rural South Africa, abstr. THLB0210. Abstr. XVI Int. AIDS Conf., Toronto, Canada, 13 to 18 August 2006.
    1. Kent, P. T, and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control, U.S. Department of Health and Human Services, Atlanta, GA.

Publication types

MeSH terms

LinkOut - more resources